SCHEMBL7440691

SCHEMBL7440691

CC/C(=N\O)c1ccc2ccccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
HDAC8 Q9BY41 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.50
ALDH1A1 P00352 2/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
PTGS1 P23219 1/20 0.46
PTGS2 P35354 1/20 0.46
KDM4E B2RXH2 1/20 0.45
HPGD P15428 1/20 0.45
PTPN1 P18031 1/20 0.44
F2 P00734 1/20 0.44
PLG P00747 1/20 0.44
PLAU P00749 1/20 0.44
KLKB1 P03952 1/20 0.44
KLK1 P06870 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7440698 1.00 GAA (0.53) GAAMEN1KMT2AHDAC8SMN1; SMN2
SCHEMBL27831966 0.84 CASP3 (0.63) GAAMEN1KMT2AHDAC8SMN1; SMN2
SCHEMBL6667377 0.83 HDAC8 (0.54) MEN1KMT2AHDAC8SMN1; SMN2ALDH1A1
SCHEMBL6669961 0.82 HDAC8 (0.47) GAAMEN1KMT2AHDAC8SMN1; SMN2
SCHEMBL23019763 0.81 GAA (0.61) GAAMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL6672136 0.81 HDAC8 (0.49) GAAMEN1KMT2AHDAC8SMN1; SMN2
SCHEMBL6069211 0.81 GAA (0.61) GAAMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL26342360 0.78 PTGS1 (0.44) MEN1KMT2ASMN1; SMN2ALDH1A1NPC1
SCHEMBL11062803 0.77 ALDH1A1 (0.53) GAAMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL6667919 0.77 HDAC8 (0.46) GAAHDAC8SMN1; SMN2ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187905-B1 PEPTIDE COMPOUND WHICH INHIBITS VIRAL PROTEINASES; VIRICIDES FOR HEPATITIS C, HEPATITIS G, AND HUMAN GB VIRUSES HOFFMANN-LA ROCHE INC. 2001-02-13 US disclosed